Gene · 9402
Papers1,586
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,586
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Computational and statistical analyses of blood hemodynamic inside cerebral aneurysms for treatment evaluation of endovascular coiling. | Sci Rep | 2023 | 37993583 | PubTator, text mining | PubMed |
| Silencing of genes by promoter hypermethylation shapes tumor microenvironment and resistance to immunotherapy in clear-cell renal cell carcinomas. | Cell Rep Med | 2023 | 37967556 | PubTator, text mining | PubMed |
| Recent progress in discovery of novel AAK1 inhibitors: from pain therapy to potential anti-viral agents. | J Enzyme Inhib Med Chem | 2023 | 37955299 | PubTator, text mining | PubMed |
| Single-cell sequencing and transcriptome analyses in the construction of a liquid-liquid phase separation-associated gene model for rheumatoid arthritis. | Front Genet | 2023 | 37953920 | PubTator, text mining | PubMed |
| Preliminary assessment of the NACA0021 trailing edge wedge for wind turbine application. | Heliyon | 2023 | 37942161 | PubTator, text mining | PubMed |
| Comprehensive analyses of immune tumor microenvironment in papillary renal cell carcinoma. | J Immunother Cancer | 2023 | 37935564 | PubTator, text mining | PubMed |
| TCR Pathway Mutations in Mature T Cell Lymphomas. | J Immunol | 2023 | 37931208 | PubTator, text mining | PubMed |
| Discovery of Chemical Scaffolds as Lysophosphatidic Acid Receptor 1 Antagonists: Virtual Screening, In Vitro Validation, and Molecular Dynamics Analysis. | ACS Omega | 2023 | 37929144 | PubTator, text mining | PubMed |
| Utilizing Heteroatom Types and Numbers from Extensive Ligand Libraries to Develop Novel hERG Blocker QSAR Models Using Machine Learning-Based Classifiers. | ACS Omega | 2023 | 37929100 | PubTator, text mining | PubMed |
| A molecular classification system for estimating radiotherapy response and anticancer immunity for individual breast cancer patients. | Front Oncol | 2023 | 37927478 | PubTator, text mining | PubMed |
| Impacts of morphology parameters on the risk of rupture in intracranial aneurysms: statistical and computational analyses. | Sci Rep | 2023 | 37923845 | PubTator, text mining | PubMed |
| Application of multi-extruded fuel injectors for mixing enhancement of hydrogen gas at scramjet engine: computational study. | Sci Rep | 2023 | 37914818 | PubTator, text mining | PubMed |
| Fuel mixing enhancement of transverse coaxial air and fuel jet by upstream shock wave on in scramjet engines: numerical study. | Sci Rep | 2023 | 37898639 | PubTator, text mining | PubMed |
| Identification of Potential JNK3 Inhibitors: A Combined Approach Using Molecular Docking and Deep Learning-Based Virtual Screening. | Pharmaceuticals (Basel) | 2023 | 37895928 | PubTator, text mining | PubMed |
| Image-Based Modeling of Drug Delivery during Intraperitoneal Chemotherapy in a Heterogeneous Tumor Nodule. | Cancers (Basel) | 2023 | 37894436 | PubTator, text mining | PubMed |
| Influence of Blood Rheology and Turbulence Models in the Numerical Simulation of Aneurysms. | Bioengineering (Basel) | 2023 | 37892900 | PubTator, text mining | PubMed |
| Exploring pathway interactions to detect molecular mechanisms of disease: 22q11.2 deletion syndrome. | Orphanet J Rare Dis | 2023 | 37872602 | PubTator, text mining | PubMed |
| Business models for local energy market and circular economy establishment in municipalities: A case study in an Austrian municipality. | Heliyon | 2023 | 37867847 | PubTator, text mining | PubMed |
| Long-term impact of post COVID-19 pandemic quarantine on eating habits changes among adult residents of Riyadh, Saudi Arabia. | Front Nutr | 2023 | 37867492 | PubTator, text mining | PubMed |
| Air pollution dispersion in Hail city: Climate and urban topography impact. | Heliyon | 2023 | 37860557 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9402/papers?page=7